Tag Archives: thrombosis

Recomendaciones de la ACC con el nuevo coronavirus

Diagnosis and Treatment of Vaccine-Induced Thrombosis

Diagnosis and Treatment of Vaccine-Induced Thrombosis

Cerebral venous sinus thrombosis is an extremely rare manifestation of cerebrovascular disease.  In the last few days, this pathology has sadly gained fame due to its association with two vector-based vaccines against SARR COV19.  These are Ad26.COV2.S (Johnson & Johnson) and ChAdOx1 nCoV-19 (AstraZeneca). There have not been any reports of thrombosis or thrombocytopenia from

Es posible esterilizar las máscaras N95 y los barbijos quirúrgicos

Thrombocytopenia and Thrombosis May Be Linked to AstraZeneca Vaccine, Analysis Reports

This is one of the first papers documenting rare thrombotic effects related to the ChAdOx1 nCoV-19 vaccine in Austria and Germany. These effects may be a type of thrombocytopenia after inoculation with the vaccine developed by Oxford University and AstraZeneca. This paper, published in the prestigious New England Journal of Medicine (NEJM), has received plenty

Historia natural de la infección asintomática por COVID-19

Major Cause of Myocardial Injury by COVID-19

The most common cause of myocardial necrosis in patient undergoing COVID-19 infection is microthrombi. These microthrombi resulted quite different in composition vs. thrombi obtained from COVID-19 negative patients and thrombi obtained from infected patients with ACS.  Myocardial injury is common in patients hospitalized for COVID-19 and has worse prognosis. Regardless its frequency, the mechanism and

Sangrados mayores en pacientes con AAS más rivaroxabán

Impact on Mortality with Rivaroxaban after Discharge

Extending thromboembolic prophylaxis with rivaroxaban in patients hospitalized for heart conditions reduce fatal and thromboembolic events by 28% without major bleeding payback.   Patients hospitalized for heart conditions are at risk of thromboembolic events, and this is why inhospital prophylaxis (in general with low molecular weight heparin) is within the standard treatment. It was not

Es posible esterilizar las máscaras N95 y los barbijos quirúrgicos

Vasculitis, Thrombosis and Angiogenesis: Covid-19´s Unique Patters

In this small, yet interesting series, we observe angiogenesis could differentiate pulmonary physiopathology by Covid-19 vs. from viral infections of similar severity (such as influenza). Being quite small, we can hardly consider it universal, or whether it could have clinical impact. Meanwhile, we keep learning about the new virus.  Progressive respiratory failure is the main

Es posible esterilizar las máscaras N95 y los barbijos quirúrgicos

Thrombosis and Thromboembolism Associated with COVID-19

Coronavirus disease 2019 (COVID-19) is a viral respiratory illness that can cause a severe acute respiratory syndrome (SARS-CoV-2), predisposing patients to thrombosis (both in veins and arteries) due to excessive inflammation, platelet activation, endothelial dysfunction, and stasis. In addition, many patients receiving antithrombotic therapy for different indications may now become infected with COVID-19, which can

Trombosis-post-TAVI

Ischemic and Bleeding Risk After Primary Angioplasty

Patients with ST-segment elevation myocardial infarction who undergo primary angioplasty are at high risk for both ischemic and bleeding events, which affect significantly both morbidity and mortality. An optimal selection of antithrombotic therapies in terms of strength and duration must take into account the timing for the procedure, since the risk for these complications may

Top